article thumbnail

Have You Missed Any FDA Data Submission Requirements? A Look at Substantial Changes and New Requirements

Cytel

1 The following December, a second version was released after public comments and, on December 16, 2014, the FDA stopped the clock, providing sponsors with a pivotal two-year window to adapt their methods of creating clinical dataset packages to comply with the FDA’s new required data standards for any study commencing after December 16, 2016.

FDA 69
article thumbnail

FDA’s OPDP Issues Third Letter of 2023

Eye on FDA

Second, a claim was made in the communication that OPDP said was not supported by the clinical studies section of the package insert. After all, back in 2016, the agency issued six letters in the month of December alone. First, while presenting the indication in the posting, there was no risk information included in the communication.

FDA 68
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sponsored content: Why choose Bethyl antibodies for your R&D

Drug Discovery World

Nat Methods 2016 Oct;13(10):823-7) that describes five conceptual pillars for validating antibodies in an application – and context-specific manner. We also offer many high-quality custom polyclonal antibody packages that are designed to suit a range of scientific needs within your budget. A proposal for validation of antibodies.

article thumbnail

Commercial interests contribute to drug use and addiction

National Institute on Drug Abuse: Nora's Blog

Cannabis products are often sold in colorful packages that mimic kid-friendly snack foods, for example, making them appealing to children and to young people. Published March 21, 2016. Prevalence of Problem Gambling: A Meta-analysis of Recent Empirical Research (2016–2022). Smoking and Tobacco Use. Published May 4, 2023.

Drugs 105
article thumbnail

Prevention and control of non-communicable diseases as a catalyst of economic growth and social well-being in Russia

The Pharma Data

These immense benefits can be achieved through investment in five proven and cost-effective intervention packages recommended by WHO to address the major NCD risk factors. . In 2016, 1 635 000 people in Russia died from NCDs while still in their prime productive years. million deaths and yield RUB 8.1

Disease 40
article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

What is likely to be the cumulative effect on innovation of the different losses in exclusivity, also given the forthcoming Patent Package which could link the review’s rules on product shortages to EU-wide compulsory licensing?

article thumbnail

Analysis Chemical Thank You Spurred by NRDC report, California senator proposes state ban on PFAS

Agency IQ

In 2016, Biomonitoring California began a study on metals and PFAS in Asian and Pacific Islander adults living in the San Francisco Bay Area (and followed this with a second study in 2017). In early January 2020, DTSC also held a workshop on PFAS in food packaging , including panel discussions and presentations on potential alternatives.